Q32 Bio logo

Q32 Bio

QTTB | NASDAQ
Chart Builder DCF Calculator
$8.29
-$0.42 (-4.82%)
At close: Nov 16, 2026, 4:00 PM ET
$8.29
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-4.82%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
72.8
Fundamentals Excellent
Market Sentiment Neutral
Moat None
Sector Rank #39/1021 (Top 4%)

Key Statistics

Market Data

Market Cap $248.07M
1D Range
8.25 8.73
52W Range
1.93 21.38

Valuation (TTM)

PE 2.65
PB 0.86
EV/EBITDA -1.18

Valuation (NTM)

Forward PE N/A
Forward PEG -0.05
Price Target $35.00
Loading financial charts...

Profile

Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States su...

Sector Healthcare
Industry Biotechnology
Employees 22
IPO Date Mar 28, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 4, 2026
EPS
-$0.26
Beat +20.41%
REV
$170K
Beat 0.00%
Next Earnings
Mar 9, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$35.00
Upside
+322.20%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.